1. Indonesia PE. Pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia. Pb. Perkeni 2015 [cited 23.01.2021). Available from URL: https://pbperkeni.or.id/wp-content/uploads/2019/01/4.-Konsensus-Pengelolaan-dan-Pencegahan-Diabetes-melitus-tipe-2-di-Indonesia-PERKENI-2015.pdf.
2.
Wang W, Lo AC. Diabetic retinopathy: pathophysiology and treatments. Int J Mol 2018; 19(6): 1816.
3.
Sasongko MB, Widyaputri F, Agni AN, et al. Prevalence of diabetic retinopathy and blindness in Indonesian adults with type 2 diabetes. Am J Ophthalmol 2017; 181: 79–87.
4.
Huang OS, Tay WT, Ong PG, et al. Prevalence and determinants of undiagnosed diabetic retinopathy and vision-threatening retinopathy in a multiethnic Asian cohort: the Singapore Epidemiology of Eye Diseases (SEED) study. Br J Ophthalmol 2015; 99(12): 1614–1621.
5.
Liu Y, Song Y, Tao L, et al. Prevalence of diabetic retinopathy among 13473 patients with diabetes mellitus in China: a cross-sectional epidemiological survey in six provinces. BMJ Open 2017; 7(1): e013199.
6.
Abougalambou SS, Abougalambou AS. Risk factors associated with diabetic retinopathy among type 2 diabetes pa-tients at teaching hospital in Malaysia. Diabetes & Metabolic Syndrome. J Clin Res Rev 2015; 9(2): 98–103.
7.
Keel S, Xie J, Foreman J, et al. The prevalence of diabetic retinopathy in Australian adults with self-reported diabetes: the National Eye Health Survey. Ophthalmology 2017; 124(7): 977–984.
8.
Thomas RL, Dunstan FD, Luzio SD, et al. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service. Br Ophthalmol 2015; 99(1): 64–68.
9.
Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA 2010; 304(6): 649–656.
10.
Raman R, Ganesan S, Pal SS, et al. Prevalence and risk factors for diabetic retinopathy in rural India. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study III (SN-DREAMS III), report no 2. BMJ Open Diabetes Res Care 2014; 2(1): e000005.
11.
Chang LY, Lee AC, Sue W. Prevalence of diabetic retinopathy at first presentation to the retinal screening service in the greater Wellington region of New Zealand 2006–2015, and implications for models of retinal screening. N Z Med J 2017; 130(1450): 78–88.
12.
Rübsam A, Parikh S, Fort PE. Role of inflammation in diabetic retinopathy. Int J Mol 2018; 19(4): 942.
13.
George M, Harper R, Balamurugan A, et al. Diabetic retinopathy and its risk factors in a population-based study. J Prim Care Community Health 2011; 2(2): 122–126.
14.
Lu J, Ma X, Zhou J, et al. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes. Diabetes Care 2018; 41(11): 2370–2376.
15.
Liu Y, Yang J, Tao L, et al. Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China. BMJ Open 2017; 7(9): e016280.
16.
Amelia R, Harahap J, Lelo A, et al. Risk analysis for cardiovascular complication based on the atherogenic index of plasma of type 2 diabetes mellitus patients in Medan, Indonesia. Family Med Prim Care Rev 2020; 22(3): 197–201.
17.
Krishnamoorthy R, Kaliaperumal R, Venkatachalam R, et al. Apolipoproteins an Early and Better Diagnostic Marker for Diabetic Retinopathy. Clin Diagn Res 2017; 11(10): NC01–NC05.
18.
Ankit BS, Mathur G, Agrawal RP, et al. Stronger relationship of serum apolipoprotein A-1 and B with diabetic retinopathy than traditional lipids. Indian J Endocrinol Metab 2017; 21(1): 102–105.
19.
Sari NM, Saraswati MR. Prevalence of Diabetic Retinopathy in Patient Type 2 Diabetes Mellitus at Internal Medicine Policlinic Sanglah HOSPITAL. E-Jurnal Medika Udayana 2013: 1090–1099.
20.
Robinet P, Wang Z, Hazen SL, et al. A simple and sensitive enzymatic method for cholesterol quantification in macro-phages and foam cells. J Lipid Res 2010; 51(11): 3364–3369.
21.
Penumarthy S, Penmetsa GS, Mannem S. Assessment of serum levels of triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in periodontitis patients. J Indian Soc 2013; 17(1): 30–35.
22.
Tseng ST, Chou ST, Low BH, et al. Risk factors associated with diabetic retinopathy onset and progression in diabetes patients: a Taiwanese cohort study. Int J Clin Exp Med 2015; 8(11): 21507–21515.
23.
Lima VC, Cavalieri GC, Lima MC, et al. Risk factors for diabetic retinopathy: a case – control study. Int J Retin Vitr 2016; 2(1): 1–7.
24.
Dewi PN, Fadrian F, Vitresia H. Profil Tingkat Keparahan Retinopati Diabetik Dengan Atau Tanpa Hipertensi pada di RSUP Dr. M. Djamil Padang. Jurnal Kesehatan Andalas 2019; 8(2): 204.
25.
Cardoso CR, Leite NC, Dib E, et al. Predictors of development and progression of retinopathy in patients with type 2 diabetes: importance of blood pressure parameters. Sci Rep 2017; 7(1): 4867.
26.
Takao T, Inoue K, Suka M, et al. Optimal cutoff values of fasting plasma glucose (FPG) variability for detecting retinopathy and the threshold of FPG levels for predicting the risk of retinopathy in type 2 diabetes: A longitudinal study over 27 years. Diabetes Res Clin Pract 2018; 140: 228–235.
27.
Hsieh YT, Hsieh MC. Fasting plasma glucose variability is an independent risk factor for diabetic retinopathy and dia-betic macular oedema in type 2 diabetes: An 8-year prospective cohort study. Clin Exp Ophthalmol 2020; 48(4): 470–476.
28.
Chatziralli IP. The role of glycemic control and variability in diabetic retinopathy. Diabetes Ther 2018; 9(1): 431–434.
29.
Liu L, Quang ND, Banu R, et al. Hypertension, blood pressure control and diabetic retinopathy in a large population-based study. PLOS ONE 2020; 15(3): e0229665.
30.
Chung JO, Park SY, Cho DH, et al. Associations between serum apolipoproteins, urinary albumin excretion rate, esti-mated glomerular filtration rate, and diabetic retinopathy in individuals with type 2 diabetes. Medicine 2019; 98(20): 15703.
31.
Zhou Y, Wang C, Shi K, et al. Relationship between dyslipidemia and diabetic retinopathy: a systematic review and meta-analysis. Medicine 2018; 97(36): e12283.
32.
Das R, Kerr R, Chakravarthy U, et al. Dyslipidemia and diabetic macular edema: a systematic review and meta-analysis. Ophthalmology 2015; 122(9): 1820–1827.
33.
Amelia R, Sari MD, Virgayanti V, et al. Effect of duration of illness and lipid profile of type 2 Diabetes Mellitus patients on diabetic retinopathy. InIOP Conference Series: Earth and Environmental Science 2021; 713(1): 012058.
34.
Ahmed RA, Khalil SN, Al-Qahtani MA. Diabetic retinopathy and the associated risk factors in diabetes type 2 patients in Abha, Saudi Arabia. J Family Community Med 2016; 23(1): 18–24.
35.
Amelia R. The correlation between Body Mass Index and self-efficacy with blood glucose level in Type 2 Diabetes Mellitus. Adv Sci Lett 2017; 23(4): 3606–3609.
36.
Anto EO, Obirikorang C, Annani-Akollor ME, et al. Evaluation of dyslipidaemia using an algorithm of lipid profile measures among newly diagnosed type II diabetes mellitus patients: A cross-sectional study at Dormaa Presbyterian Hospital, Ghana. Medicina 2019; 55(7): 392.
37.
Susilo AS, Zulfian Z, Artini I. Korelasi Nilai HbA1c dengan Kadar Kolesterol Total pada Pasien Diabetes Mellitus Tipe 2. Jurnal Ilmiah Kesehatan Sandi Husada 2020; 12(2): 640–645.
38.
Amelia R, Damanik HA, Lindarto D, et al. The correlation between the level of HbA1c with total serum cholesterol of uncontrolled Type 2 diabetes mellitus patients in Binjai, Sumatera Utara. Adv Sci Lett 2017; 23(4): 3610–3613.
39.
Amin ZA, Islam QU, Mehboob MA. Comparison of serum lipid profile in Type-2 Diabetics with and without retinopa-thy in Pakistani population. PaK J Med Sci 2016; 32(6): 1349–1353.
40.
Nsengiyumva V, Fernando ME, Moxon JV, et al. The association of circulating 25-hydroxyvitamin D concentration with peripheral arterial disease: a meta-analysis of observational studies. Atherosclerosis 2015; 243(2): 645–651.
41.
Alcubierre N, Valls J, Rubinat E, et al. Vitamin D deficiency is associated with the presence and severity of diabetic retinopathy in type 2 diabetes mellitus. J Diabetes Res 2015; 2015: 374178.
42.
Liang F, Wang K, Zhang H, et al. Serum 25-hydroxyvitamin D levels and diabetic retinopathy: A systematic meta-analysis. Int J Clin Exp Pathol 2016; 9(12): 12843–12848.
43.
Farias LB, Lavinsky D, Benfica CZ, et al. Microalbuminuria is associated with early retinal neurodegeneration in patients with type 2 diabetes. Ophthalmic Surg Lasers Imaging Retina 2018; 49(9): e36–e43.
44.
Lv X, Ran X, Chen X, et al. Early-onset type 2 diabetes: A high-risk factor for proliferative diabetic retinopathy (PDR) in patients with microalbuminuria. Medicine 2020; 99(19): e20189.
45.
Lee MK, Han KD, Lee JH, et al. Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes. Sci Rep 2017; 7(1): 1–8.
46.
Kurniati A, Tahono T. Angka Banding Albumin Kreatinin Air Kemih dan HbA1c Serta Estimasi Laju Filtrasi Glomerulus Pada Pasien Diabetes Melitus Tipe 2 (Urinary Albumin to Creatinine Ratio with HbA1c and Estimated Glomerulo Filtra-tion Rate in Type 2 Diabetes Mellitus Patients). Indonesian J Clin Pathol Med Lab 2018; 21: 250–256.